Novyra Pharmachem Ltd
- Market cap
- ₹ 5 Cr.
- P/E
- 92.4x
- P/B
- 8.65x
- 52-week range
- 7.12 – 16.55
- ROE
- −162%
- ROCE
- −162.2%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Agricultural Food & other Products
- Industry
- Tea & Coffee
- Listed on
- BSE
About
Novyra Pharmachem Limited, formerly Bansisons Tea Industries Limited, is an India-based company. The Company is engaged in business activities relating to pharmaceuticals, chemicals and allied trading/business operations. Its segments include Pharma, Real Estate, and Tea Estate.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Tea & Coffee: 29 companies →Novyra Pharmachem Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)92.4 against a typical 18: pricier than most peers (1st = cheapest).23rd of 29
- Size₹ 5.4 Cr. market value against a typical ₹ 118.9 Cr. (1st = largest).24th of 25
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 2 |
| Operating Profit | −0 | −0 | −0 | 0 | 0 | −0 | −0 | −0 | 0 | −0 | −5 | −0 |
| OPM % | — | — | — | — | — | — | — | — | — | — | −5,330% | −1.2% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −0 | −0 | −0 | 0 | 0 | −0 | −0 | −0 | 0 | −0 | −5 | −0 |
| Tax % | 0% | 0% | 0% | — | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | −0 | −0 | −0 | 0 | 0 | −0 | −0 | −0 | 0 | −0 | −5 | −0 |
| EPS in Rs | −0.09 | −0.02 | −0.06 | 0 | 0 | −0.02 | −0.08 | −0.02 | 0.02 | −0.05 | −8.44 | −0.03 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- −21%
- 5 Years
- −8%
- 3 Years
- −13%
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- −7,586%
- 10 Years
- —
- 5 Years
- 23%
- 3 Years
- 17%
- TTM
- —
- 10 Years
- −10%
- 5 Years
- −20%
- 3 Years
- −37%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Novyra Pharmachem Ltd | ₹ 8.08 | ₹ 5 Cr. | 92.4x | 8.7x | −162% | — |
| Nestle India | ₹ 1,265.00 | ₹ 2,43,932 Cr. | 77.9x | 51.7x | — | 15.6% |
| Britannia Industries | ₹ 4,780.00 | ₹ 1,15,135 Cr. | 46.2x | 23.2x | — | 13.4% |
| Tata Consumer Products | ₹ 977.20 | ₹ 96,713 Cr. | 61.2x | 4.5x | — | 8.3% |
| Patanjali Foods | ₹ 367.50 | ₹ 39,988 Cr. | 20.6x | 3.1x | — | 4.6% |
| Godrej Industries | ₹ 1,041.40 | ₹ 35,035 Cr. | 29.1x | 3x | — | 9.5% |
Management
- Jayanta Kundu
- Chief Financial Officer
- Nisha Gattani
- Company Secretary, Compliance Officer
- Sandeep Kumar Agarwal
- Whole Time Director
- Anilkumar Mohanbhai Amreliya
- Additional Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.